Connection
Michael Schoenbaum to Psychiatry
This is a "connection" page, showing publications Michael Schoenbaum has written about Psychiatry.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.898 |
|
|
|
-
Schoenbaum M, Colpe L. Challenges to Behavioral Health and Injury Surveillance During the COVID-19 Pandemic. JAMA Psychiatry. 2021 08 01; 78(8):924-925.
Score: 0.555
-
Olfson M, Zhang V, Schoenbaum M, King M. Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others. Health Aff (Millwood). 2020 06; 39(6):984-992.
Score: 0.128
-
Olfson M, King M, Schoenbaum M. Stimulant Treatment of Young People in the United States. J Child Adolesc Psychopharmacol. 2016 08; 26(6):520-6.
Score: 0.096
-
Olfson M, King M, Schoenbaum M. Treatment of Young People With Antipsychotic Medications in the United States. JAMA Psychiatry. 2015 Sep; 72(9):867-74.
Score: 0.092
-
Sultan RS, Correll CU, Schoenbaum M, King M, Walkup JT, Olfson M. National Patterns of Commonly Prescribed Psychotropic Medications to Young People. J Child Adolesc Psychopharmacol. 2018 04; 28(3):158-165.
Score: 0.027